{"parse":{"title":"Global HIV Vaccine Enterprise","pageid":28810868,"revid":807778042,"text":{"*":"<div class=\"mw-parser-output\"><div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Global_HIV_Vaccine_Enterprise.jpg\" class=\"image\"><img alt=\"Global HIV Vaccine Enterprise.jpg\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/a/a0/Global_HIV_Vaccine_Enterprise.jpg/220px-Global_HIV_Vaccine_Enterprise.jpg\" width=\"220\" height=\"56\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/a/a0/Global_HIV_Vaccine_Enterprise.jpg/330px-Global_HIV_Vaccine_Enterprise.jpg 1.5x, //upload.wikimedia.org/wikipedia/en/a/a0/Global_HIV_Vaccine_Enterprise.jpg 2x\" data-file-width=\"382\" data-file-height=\"97\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Global_HIV_Vaccine_Enterprise.jpg\" class=\"internal\" title=\"Enlarge\"></a></div></div></div></div>\n<p>The <b>Global HIV Vaccine Enterprise</b> (the Enterprise) is an alliance of organizations formed to accelerate the search for an HIV vaccine.  Initially proposed in Science magazine in 2003 <sup id=\"cite_ref-klausner_1-0\" class=\"reference\"><a href=\"#cite_note-klausner-1\">&#91;1&#93;</a></sup> and developed by scientists, health experts and policy makers, the concept of the Enterprise received support from the <a href=\"/wiki/G8\" class=\"mw-redirect\" title=\"G8\">G8</a> the following year. The primary aim of the organization is to provide leadership in efforts to reverse the AIDS epidemic.  The organization, based in New York City, was founded by representatives from <a href=\"/wiki/Bill_%26_Melinda_Gates_Foundation\" title=\"Bill &amp; Melinda Gates Foundation\">The Gates Foundation</a>, NIH, <a href=\"/wiki/Joint_United_Nations_Programme_on_HIV/AIDS\" title=\"Joint United Nations Programme on HIV/AIDS\">WHO-UNAIDS</a>, European Commission, <a href=\"/wiki/Wellcome_Trust\" title=\"Wellcome Trust\">Wellcome Trust</a>, International AIDS Vaccine Initiative, French National Agency for Research on AIDS and Viral Hepatitis.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-klausner_1-1\" class=\"reference\"><a href=\"#cite_note-klausner-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#History\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Scientific_Strategic_Plan\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Scientific Strategic Plan</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Activities\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Activities</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#References\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Further_reading\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Further reading</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#External_links\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Global_HIV_Vaccine_Enterprise&amp;action=edit&amp;section=1\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In June 2003, a group of 24 individuals in the field of HIV vaccines published a Policy Forum article in the journal Science <sup id=\"cite_ref-klausner_1-2\" class=\"reference\"><a href=\"#cite_note-klausner-1\">&#91;1&#93;</a></sup> proposing the creation of the Global HIV Vaccine Enterprise. The article asserted that current attempts to develop such a vaccine were insufficient and that a renewed HIV vaccine research effort was required. The <a href=\"/wiki/G8\" class=\"mw-redirect\" title=\"G8\">G8</a> pledged support in July 2004 and the following year, the Enterprise published the Scientific Strategic Plan in the journal PLoS Medicine.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup> The activities of the organization are managed by a Secretariat, overseen by a Board of Directors and advised by the Enterprise Council and a Science Committee.\n</p>\n<h2><span class=\"mw-headline\" id=\"Scientific_Strategic_Plan\">Scientific Strategic Plan</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Global_HIV_Vaccine_Enterprise&amp;action=edit&amp;section=2\" title=\"Edit section: Scientific Strategic Plan\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Following the foundation of the Enterprise, the organization published its Scientific Strategic Plan for accelerating HIV vaccine research in the February 2005 issue of Public Library of Science (PLoS) \u2014 Medicine.<sup id=\"cite_ref-plan_6-0\" class=\"reference\"><a href=\"#cite_note-plan-6\">&#91;6&#93;</a></sup> The plan described the major challenges facing the field and made recommendations in six priority areas. The primary aims of the 2005 Plan were to propose new activities in the field, increase collaboration and acquire funding commitments from government and non-government organizations.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>\nIn September 2010, the Enterprise published the 2010 Scientific Strategic Plan <sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup> in <a href=\"/wiki/Nature_Medicine\" title=\"Nature Medicine\">Nature Medicine</a>.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (September 2013)\">citation needed</span></a></i>&#93;</sup> The organization\u2019s current Plan aims to assess the impact of the 2005 Plan and further advancements in the field.\nThe development of the 2010 Plan is driven by five Working Groups made up of more than 100 researchers representing different scientific approaches.\n</p>\n<h2><span class=\"mw-headline\" id=\"Activities\">Activities</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Global_HIV_Vaccine_Enterprise&amp;action=edit&amp;section=3\" title=\"Edit section: Activities\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Consistent with its mission to foster collaboration in the field, the Enterprise participates in and hosts conferences throughout the year including the <a href=\"/wiki/International_AIDS_Conference\" class=\"mw-redirect\" title=\"International AIDS Conference\">International AIDS Conference</a> in Vienna and the AIDS Vaccine 2010 Conference in Atlanta, Georgia.\n</p><p>In collaboration with the <a href=\"/wiki/National_Press_Foundation\" title=\"National Press Foundation\">National Press Foundation</a> and the <a href=\"/wiki/International_AIDS_Society\" title=\"International AIDS Society\">International AIDS Society</a>, the Enterprise organized a training program for science journalists to report on the conferences. \n</p><p>The Young and Early Career Investigators (YECIs) initiative was formed by the Enterprise to recruit new scientists in the field. The group is chaired by representatives from Harvard Medical School and University of KwaZulu Natal <sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Global_HIV_Vaccine_Enterprise&amp;action=edit&amp;section=4\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-klausner-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-klausner_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-klausner_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-klausner_1-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Klausner, R. D.; Fauci, A. S.; Corey, L.; Nabel, G. J.; Gayle, H.; Berkley, S.; Haynes, B. F.; Baltimore, D.; Collins, C.; Douglas, R. G.; Esparza, J.; Francis, D. P.; Ganguly, N. K.; Gerberding, J. L.; Johnston, M. I.; Kazatchkine, M. D.; McMichael, A. J.; Makgoba, M. W.; Pantaleo, G.; Piot, P.; Shao, Y.; Tramont, E.; Varmus, H.; Wasserheit, J. N. (2003). \"MEDICINE: Enhanced: The Need for a Global HIV Vaccine Enterprise\". <i>Science</i>. <b>300</b> (5628): 2036\u20132039. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.1086916\">10.1126/science.1086916</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12829768\">12829768</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=MEDICINE%3A+Enhanced%3A+The+Need+for+a+Global+HIV+Vaccine+Enterprise&amp;rft.volume=300&amp;rft.issue=5628&amp;rft.pages=2036-2039&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1086916&amp;rft_id=info%3Apmid%2F12829768&amp;rft.aulast=Klausner&amp;rft.aufirst=R.+D.&amp;rft.au=Fauci%2C+A.+S.&amp;rft.au=Corey%2C+L.&amp;rft.au=Nabel%2C+G.+J.&amp;rft.au=Gayle%2C+H.&amp;rft.au=Berkley%2C+S.&amp;rft.au=Haynes%2C+B.+F.&amp;rft.au=Baltimore%2C+D.&amp;rft.au=Collins%2C+C.&amp;rft.au=Douglas%2C+R.+G.&amp;rft.au=Esparza%2C+J.&amp;rft.au=Francis%2C+D.+P.&amp;rft.au=Ganguly%2C+N.+K.&amp;rft.au=Gerberding%2C+J.+L.&amp;rft.au=Johnston%2C+M.+I.&amp;rft.au=Kazatchkine%2C+M.+D.&amp;rft.au=McMichael%2C+A.+J.&amp;rft.au=Makgoba%2C+M.+W.&amp;rft.au=Pantaleo%2C+G.&amp;rft.au=Piot%2C+P.&amp;rft.au=Shao%2C+Y.&amp;rft.au=Tramont%2C+E.&amp;rft.au=Varmus%2C+H.&amp;rft.au=Wasserheit%2C+J.+N.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlobal+HIV+Vaccine+Enterprise\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Berkley, S.; Bertram, K.; Delfraissy, J. F. O.; Draghia-Akli, R.; Fauci, A.; Hallenbeck, C.; Kagame, M. J.; Kim, P.; Mafubelu, D.; Makgoba, M. W.; Piot, P.; Walport, M.; Warren, M.; Yamada, T.; Esparza, J.; Hankins, C.; Johnston, M. I.; L\u00e9vy, Y.; Romaris, M.; Ahmed, R.; Bernstein, A. (2010). \"The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise\". <i>Nature Medicine</i>. <b>16</b> (9): 981\u2013989. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nm0910-981\">10.1038/nm0910-981</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20823883\">20823883</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Medicine&amp;rft.atitle=The+2010+scientific+strategic+plan+of+the+Global+HIV+Vaccine+Enterprise&amp;rft.volume=16&amp;rft.issue=9&amp;rft.pages=981-989&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1038%2Fnm0910-981&amp;rft_id=info%3Apmid%2F20823883&amp;rft.aulast=Berkley&amp;rft.aufirst=S.&amp;rft.au=Bertram%2C+K.&amp;rft.au=Delfraissy%2C+J.+F.+O.&amp;rft.au=Draghia-Akli%2C+R.&amp;rft.au=Fauci%2C+A.&amp;rft.au=Hallenbeck%2C+C.&amp;rft.au=Kagame%2C+M.+J.&amp;rft.au=Kim%2C+P.&amp;rft.au=Mafubelu%2C+D.&amp;rft.au=Makgoba%2C+M.+W.&amp;rft.au=Piot%2C+P.&amp;rft.au=Walport%2C+M.&amp;rft.au=Warren%2C+M.&amp;rft.au=Yamada%2C+T.&amp;rft.au=Esparza%2C+J.&amp;rft.au=Hankins%2C+C.&amp;rft.au=Johnston%2C+M.+I.&amp;rft.au=L%C3%A9vy%2C+Y.&amp;rft.au=Romaris%2C+M.&amp;rft.au=Ahmed%2C+R.&amp;rft.au=Bernstein%2C+A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlobal+HIV+Vaccine+Enterprise\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gewin, V. (2007). \"Alan Bernstein, executive director, Global HIV Vaccine Enterprise, Seattle, Washington\". <i>Nature</i>. <b>450</b> (7167): 316\u2013317. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nj7167-316a\">10.1038/nj7167-316a</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Alan+Bernstein%2C+executive+director%2C+Global+HIV+Vaccine+Enterprise%2C+Seattle%2C+Washington&amp;rft.volume=450&amp;rft.issue=7167&amp;rft.pages=316-317&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1038%2Fnj7167-316a&amp;rft.aulast=Gewin&amp;rft.aufirst=V.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlobal+HIV+Vaccine+Enterprise\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ross, A. L.; Br\u00e5ve, A.; Scarlatti, G.; Manrique, A.; Buonaguro, L. (2010). \"Progress towards development of an HIV vaccine: Report of the AIDS Vaccine 2009 Conference\". <i>The Lancet Infectious Diseases</i>. <b>10</b> (5): 305\u2013316. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S1473-3099%2810%2970069-4\">10.1016/S1473-3099(10)70069-4</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20417413\">20417413</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet+Infectious+Diseases&amp;rft.atitle=Progress+towards+development+of+an+HIV+vaccine%3A+Report+of+the+AIDS+Vaccine+2009+Conference&amp;rft.volume=10&amp;rft.issue=5&amp;rft.pages=305-316&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1016%2FS1473-3099%2810%2970069-4&amp;rft_id=info%3Apmid%2F20417413&amp;rft.aulast=Ross&amp;rft.aufirst=A.+L.&amp;rft.au=Br%C3%A5ve%2C+A.&amp;rft.au=Scarlatti%2C+G.&amp;rft.au=Manrique%2C+A.&amp;rft.au=Buonaguro%2C+L.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlobal+HIV+Vaccine+Enterprise\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\">Coordinating Committee of the Global HIV/AIDS Vaccine Enterprise (2005) The Global HIV/AIDS Vaccine Enterprise: Scientific Strategic Plan. PLoS Med 2(2): e25. 18 January 2005</span>\n</li>\n<li id=\"cite_note-plan-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-plan_6-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Global HIV/AIDS Vaccine Enterprise (2005). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC544553\">\"The Global HIV/AIDS Vaccine Enterprise: Scientific Strategic Plan\"</a>. <i>PLoS Medicine</i>. <b>2</b> (2): e25. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1371/journal.pmed.0020025\">10.1371/journal.pmed.0020025</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC544553\">544553</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15740411\">15740411</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLoS+Medicine&amp;rft.atitle=The+Global+HIV%2FAIDS+Vaccine+Enterprise%3A+Scientific+Strategic+Plan&amp;rft.volume=2&amp;rft.issue=2&amp;rft.pages=e25&amp;rft.date=2005&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC544553&amp;rft_id=info%3Apmid%2F15740411&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pmed.0020025&amp;rft.au=Global+HIV%2FAIDS+Vaccine+Enterprise&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC544553&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlobal+HIV+Vaccine+Enterprise\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"position:relative; top: -2px;\"><a href=\"/wiki/Open_access\" title=\"open access publication \u2013 free to read\"><img alt=\"open access publication \u2013 free to read\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/9px-Open_Access_logo_PLoS_transparent.svg.png\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/14px-Open_Access_logo_PLoS_transparent.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/18px-Open_Access_logo_PLoS_transparent.svg.png 2x\" data-file-width=\"640\" data-file-height=\"1000\" /></a></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Montefiori, D.; Sattentau, Q.; Flores, J.; Esparza, J.; Mascola, J.; Working Group convened by the Global HIV Vaccine Enterprise (2007). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2100141\">\"Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions\"</a>. <i>PLoS Medicine</i>. <b>4</b> (12): e348. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1371/journal.pmed.0040348\">10.1371/journal.pmed.0040348</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2100141\">2100141</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18052607\">18052607</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLoS+Medicine&amp;rft.atitle=Antibody-Based+HIV-1+Vaccines%3A+Recent+Developments+and+Future+Directions&amp;rft.volume=4&amp;rft.issue=12&amp;rft.pages=e348&amp;rft.date=2007&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2100141&amp;rft_id=info%3Apmid%2F18052607&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pmed.0040348&amp;rft.aulast=Montefiori&amp;rft.aufirst=D.&amp;rft.au=Sattentau%2C+Q.&amp;rft.au=Flores%2C+J.&amp;rft.au=Esparza%2C+J.&amp;rft.au=Mascola%2C+J.&amp;rft.au=Working+Group+convened+by+the+Global+HIV+Vaccine+Enterprise&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2100141&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlobal+HIV+Vaccine+Enterprise\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\">Berkley, Seth et al. \"The Need for a Global HIV Vaccine Enterprise\", Nature Medicine . 2010.</span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\">IAVI. \"Nipping HIV In the Bud\", IAVI Report Volume 14 No. 1, New York, January\u2013February 2010.</span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"Further_reading\">Further reading</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Global_HIV_Vaccine_Enterprise&amp;action=edit&amp;section=5\" title=\"Edit section: Further reading\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li>IAVI. \"Nipping HIV In the Bud\", IAVI Report Volume 14 No. 1, New York, January\u2013February 2010.</li>\n<li>Keeton, Claire. \"Top 10 lessons learned from HIV vaccine trials presented at M2010\", Times Live, New York City, 25 May 2010. Retrieved on 2010-06-14.</li>\n<li>Farlow, Andrew. \"Purchase Commitments: What is the Fit? A Response to \u2018Making Markets\u2019 and \u2018Strong Medicine\u2019\", Submission to: Commission on Intellectual Property Rights, Innovation and Public Health, University of Oxford, 22 March 2005.</li></ul>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Global_HIV_Vaccine_Enterprise&amp;action=edit&amp;section=6\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.hivvaccineenterprise.org/\">Official website</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://twitter.com/HIVEnterprise/\">Twitter account</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.facebook.com/pages/New-York-NY/Global-HIV-Vaccine-Enterprise/149450963068\">Facebook page</a></li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw1330\nCached time: 20180909013707\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.144 seconds\nReal time usage: 0.190 seconds\nPreprocessor visited node count: 712/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 18335/2097152 bytes\nTemplate argument size: 595/2097152 bytes\nHighest expansion depth: 11/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 13292/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.073/10.000 seconds\nLua memory usage: 2.98 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  157.601      1 -total\n 61.41%   96.782      1 Template:Reflist\n 44.30%   69.811      6 Template:Cite_journal\n 38.09%   60.033      1 Template:Fact\n 26.58%   41.896      1 Template:Fix\n 17.03%   26.838      2 Template:Category_handler\n  5.95%    9.384      1 Template:Delink\n  1.94%    3.057      1 Template:Fix/category\n  1.40%    2.210      1 Template:Main_other\n  0.87%    1.370      1 Template:Open_access\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:28810868-0!canonical and timestamp 20180909013707 and revision id 807778042\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_September_2013"},{"sortkey":"","*":"HIV_vaccine_research"},{"sortkey":"","*":"Vaccination-related_organizations"},{"sortkey":"","*":"HIV/AIDS_organizations"},{"sortkey":"","*":"International_medical_and_health_organizations"}],"links":[{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from September 2013"},{"ns":0,"exists":"","*":"Open access"},{"ns":0,"exists":"","*":"Bill & Melinda Gates Foundation"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"G8"},{"ns":0,"exists":"","*":"International AIDS Conference"},{"ns":0,"exists":"","*":"International AIDS Society"},{"ns":0,"exists":"","*":"Joint United Nations Programme on HIV/AIDS"},{"ns":0,"exists":"","*":"National Press Foundation"},{"ns":0,"exists":"","*":"Nature Medicine"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Wellcome Trust"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"}],"templates":[{"ns":10,"exists":"","*":"Template:Fact"},{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Open access"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg","Open_Access_logo_PLoS_transparent.svg","Global_HIV_Vaccine_Enterprise.jpg"],"externallinks":["//doi.org/10.1126/science.1086916","//www.ncbi.nlm.nih.gov/pubmed/12829768","//doi.org/10.1038/nm0910-981","//www.ncbi.nlm.nih.gov/pubmed/20823883","//doi.org/10.1038/nj7167-316a","//doi.org/10.1016/S1473-3099(10)70069-4","//www.ncbi.nlm.nih.gov/pubmed/20417413","//www.ncbi.nlm.nih.gov/pmc/articles/PMC544553","//doi.org/10.1371/journal.pmed.0020025","//www.ncbi.nlm.nih.gov/pubmed/15740411","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2100141","//doi.org/10.1371/journal.pmed.0040348","//www.ncbi.nlm.nih.gov/pubmed/18052607","http://www.hivvaccineenterprise.org/","https://twitter.com/HIVEnterprise/","http://www.facebook.com/pages/New-York-NY/Global-HIV-Vaccine-Enterprise/149450963068"],"sections":[{"toclevel":1,"level":"2","line":"History","number":"1","index":"1","fromtitle":"Global_HIV_Vaccine_Enterprise","byteoffset":3653,"anchor":"History"},{"toclevel":1,"level":"2","line":"Scientific Strategic Plan","number":"2","index":"2","fromtitle":"Global_HIV_Vaccine_Enterprise","byteoffset":4521,"anchor":"Scientific_Strategic_Plan"},{"toclevel":1,"level":"2","line":"Activities","number":"3","index":"3","fromtitle":"Global_HIV_Vaccine_Enterprise","byteoffset":6381,"anchor":"Activities"},{"toclevel":1,"level":"2","line":"References","number":"4","index":"4","fromtitle":"Global_HIV_Vaccine_Enterprise","byteoffset":7188,"anchor":"References"},{"toclevel":1,"level":"2","line":"Further reading","number":"5","index":"5","fromtitle":"Global_HIV_Vaccine_Enterprise","byteoffset":7216,"anchor":"Further_reading"},{"toclevel":1,"level":"2","line":"External links","number":"6","index":"6","fromtitle":"Global_HIV_Vaccine_Enterprise","byteoffset":7725,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Global HIV Vaccine Enterprise","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q5570354"}]}}